[Choice of anti-helicobacter treatment of gastroduodenal ulcer associated with helicobater pylori].

AIM

Choice of optimal antihelicobacter (AH) treatment of ulcer.

MATERIALS AND METHODS

249 outpatients with duodenal ulcer associated with Helicobacter pylori entered a blind multicenter controlled trial. The patients were given one of the following drugs: metronidazole, tonidazol, amoxicilline, clarithromycin, rovamycin, omeprazole, azitromycin.

RESULTS

Of all the drugs used, rovamycin appeared preferable as it has high AH activity, is safe and cost-effective.

CONCLUSION

Rovamycin has a high AH activity and can be applied for treatment of diseases associated with Helicobacter pylori as a drug of choice.